YCM
CEROW

Yakira Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Yakira Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,999
Closed -$725 – 233
2025
Q1 		$725 Hold
49,999
– – ﹤0.01% 205
2024
Q4 		$415 Hold
49,999
– – ﹤0.01% 236
2024
Q3 		$255 Hold
49,999
– – ﹤0.01% 265
2024
Q2 		$1.01K Hold
49,999
– – ﹤0.01% 267
2024
Q1 		$3.41K Hold
49,999
– – ﹤0.01% 266
2023
Q4 		$1.38K Hold
49,999
– – ﹤0.01% 303
2023
Q3 		$3.58K Hold
49,999
– – ﹤0.01% 308
2023
Q2 		$3.27K Buy
+49,999
New +$2.17K ﹤0.01% 308

Other funds holding CEROW

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Yakira Capital Management's CEROW Position: Q2 2025 in Review

Yakira Capital Management sold out of CERo Therapeutics Warrants (CEROW) in Q2 2025, closing a stake of 49,999 shares — an estimated $725 sold.

Yakira Capital Management first reported a position in CEROW in Q2 2023 and held it in 8 quarters. The position peaked at $3.58K in Q3 2023. 23 funds tracked by Wall St. Rank hold CEROW as of Q2 2025.

  • Yakira Capital Management reported no remaining CERo Therapeutics Warrants position as of Q2 2025 after selling out during the quarter.
  • Yakira Capital Management sold 49,999 CERo Therapeutics Warrants shares in Q2 2025, an estimated $725.
  • Yakira Capital Management first reported a position in CERo Therapeutics Warrants in Q2 2023 and held it in 8 quarters.
  • Yakira Capital Management's CERo Therapeutics Warrants position peaked at $3.58K in Q3 2023.
  • 23 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q2 2025.

Based on Yakira Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.